Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05801809

Understanding the Effects of Transauricular Vagus Nerve Stimulation on Neural Networks and Autonomic Nervous System

Understanding the Effects of Non-invasive Transauricular Vagus Nerve Stimulation (taVNS) on Neural Networks and Autonomic Nervous System: a Randomized Double-blind Sham-control Mechanistic Trial in Healthy Participants

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Spaulding Rehabilitation Hospital · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

This trial aims to perform an exploratory, mechanistic, randomized double-blind sham-control trial in healthy participants to assess the physiologic effects of a single 60 minutes session of bilateral taVNS, on neural networks and autonomic function.

Detailed description

Several studies have shown promising results of taVNS to treat various disorders such as depression, anxiety, Alzheimer's disease, headache, obesity, and diabetes. However, no mechanistic studies have investigated the taVNS neural network and autonomic nervous system effects of this technique. Therefore, we aim to assess how taVNS can affect EEG metrics and HRV and assess its safety. Also, we aim to evaluate predictors that can influence the response to taVNS, so understanding the variables associated with response to taVNS can help the design of future clinical trials to maximize the effects of this intervention.

Conditions

Interventions

TypeNameDescription
DEVICETransauricular vagus nerve stimulation (taVNS)Transauricular vagus nerve stimulation (taVNS) is a simple technique in which small surface electrodes are placed over the skin of the ear that are thought to be innervated by the auricular branch of the vagus nerve (ABVN).

Timeline

Start date
2023-04-26
Primary completion
2023-09-23
Completion
2026-03-01
First posted
2023-04-06
Last updated
2025-12-10
Results posted
2025-12-10

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05801809. Inclusion in this directory is not an endorsement.